4. Pulpotomy (MTA) versus pulpotomy (CH+NaOCl).
Outcome | Time point (months) | No. of studies | Risk ratio (95% CI) |
Clinical failure | 6 and 12 | 1 | Not estimable* |
Radiological failure | 6 | 1 | Not estimable* |
12 | 1 | 0.09 (0.01, 1.58) | |
Soft tissue pathology | 6 and 12 | 1 | Not estimable* |
Pathologic mobility | 6 and 12 | 1 | Not estimable* |
Adjacent tissue inflammation | 6 and 12 | 1 | Not estimable* |
Pathologic radiolucency | 6 | 1 | Not estimable* |
12 | 1 | 0.14 (0.01, 2.66) | |
Pathologicroot resorption | 6 | 1 | Not estimable* |
12 | 1 | 0.14 (0.01, 2.66) | |
Pulp canal obliteration | 6 | 1 | Not estimable* |
12 | 1 | 0.44 (0.15, 1.29) |
*due to lack of events
Abbreviations ‐ CI: confidence interval; MTA: mineral trioxide aggregate; CH: calcium hydroxyde; NaOCl; sodium hypochlorite